Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2007; Volume 189, Supplement 653
The 86th Annual Meeting of The German Physiological Society
3/25/2007-3/28/2007
Hannover, Germany


UROTENSIN-II ACTIVATES RAC-1 AND ROS PRODUCTION IN PULMONARY ARTERY SMOOTH MUSCLE CELLS INVOLVING GA I PROTEINS
Abstract number: O02-5

Djordjevic1 T, Schafer1 N, Weitnauer1 M, Gorlach1 A

1Experimentelle Kinderkardiologie, Deutsches Herzzentrum

The vascactive peptide urotensin-II (hU-II) has been associated with vascular remodelling processes in pulmonary hypertension (PH). hU-II acts via the G-protein coupled receptor GPR14. However, the mechanisms mediating GPR14-signalling remain unclear. ROS generated by NADPH oxidases can act as signalling molecules in vascular cells. Since the GTPase Rac-1 is required for activation of this enzyme we investigated whether hU-II and GPR14 can activate Rac-1 and ROS production in pulmonary artery smooth muscle cells (PASMC). hU-II rapidly activated Rac-1 and this response was abolished by the GPR14 antagonist urantide. hU-II also increased ROS levels within 5 minutes. Overexpression of GPR14 enhanced ROS production by hU-II, whereas urantide, dominant-negative RacT17N or pertussis toxin inhibited hU-II-induced Rac-1 activation and ROS generation indicating coupling of GPR14 to Gai proteins. Indeed, transfection of dominant-negative Gai3 completely diminished hU-II-stimulated ROS generation and Rac-1 activation. These results show that hU-II is a potent activator of Rac-1 leading to rapid ROS generation involving GPR14 and Gai proteins. hU-II- mediated activation of the NADPH oxidase in PASMC may thus contribute to vascular remodeling.

To cite this abstract, please use the following information:
Acta Physiologica 2007; Volume 189, Supplement 653 :O02-5

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE